Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion type Assertion NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_head.
- NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion description "[Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_provenance.
- NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion evidence source_evidence_literature NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_provenance.
- NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion SIO_000772 24312355 NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_provenance.
- NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion wasDerivedFrom befree-2016 NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_provenance.
- NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion wasGeneratedBy ECO_0000203 NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_provenance.